Quick facts
English
  • Ελληνικα
  • Türkçe
  • Español
  • Русский
  • Italiano
  • Français
  • العربية
  • Português BR
DISCOVER Alpha-Mannosidosis

Sitemap

  • Cookie policy
  • Home HCP
    • About Alpha-Mannosidosis
      • Disease progression
      • Impact of the disease
      • Mechanism of disease
    • Disease management
      • General management of Alpha-Mannosidosis
      • Specific treatments for Alpha-Mannosidosis
    • Symptoms and diagnosis
      • Clinical characteristics of Alpha-Mannosidosis
      • Diagnostic algorithm
      • Symptoms and red flags
  • Home patient
    • About Alpha-Mannosidosis
      • Symptoms of Alpha-Mannosidosis
    • Diagnosis
    • Living with Alpha-Mannosidosis
      • Alpha-Mannosidosis Tips
    • Tools and Resources
      • Alpha-Mannosidosis Community
  • Homepage
  • Privacy Policy
  • Quick facts
  • Sitemap
  • Term of use

The information on this website is intended only to provide knowledge of Alpha-Mannosidosis disease health topics. This information should not be used in place of advice from your GP or other healthcare professional. If in doubt please contact your doctor for advice. This website has been produced by Chiesi Pharmaceuticals. The website has been developed in accordance with industry and legal standards to provide information for healthcare professionals and the general public about Alpha-Mannosidosis disease health topics. Chiesi Pharmaceuticals makes every reasonable effort to include accurate and current information. However, the information provided in this website is not exhaustive.

For Patients & Caregivers: in case of need to report an adverse drug reaction, please refer to your physician, asking him to fill in and submit the relevant case report to the concerned Health Authority, according to the Pharmacovigilance requirements in force in your Country. Nevertheless, please be kindly reminded that each patient can report any such cases directly to the national reporting system.

For HCPs: in case you want to report an adverse drug reaction you become aware of, please report it to your Health Authority according to the requirements set by the pharmacovigilance legislation.

ALL_26_1112

  • Chiesi Global Rare Disease
  • Chiesi Group
  • Term of use
  • Privacy Policy
  • Cookie policy

© 2026 CHIESI Farmaceutici S.p.A. Vat 01513360345, Payed Up Capital: Euro 75.000.000, Companies Register Office - Parma N.15739, REA: 159271.

yt fb li
Chiesi global rare disease